Initial in vitro studies using 667 glioblastoma cells demonstrated that TXM-CB4 was 100–200 fold more potent than NAC in reducing oxygen-consumption rate, indicating a pronounced inhibitory effect on mitochondrial respiration. The gene discussed is NLRP1; the disease is glioblastoma.